Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsSecurities - TradableShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Accounts Payables: 2022-2024

Historic Accounts Payables for Praxis Precision Medicines (PRAX) over the last 3 years, with Dec 2024 value amounting to $12.5 million.

  • Praxis Precision Medicines' Accounts Payables rose 105.32% to $30.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.8 million, marking a year-over-year increase of 105.32%. This contributed to the annual value of $12.5 million for FY2024, which is 115.44% up from last year.
  • Praxis Precision Medicines' Accounts Payables amounted to $12.5 million in FY2024, which was up 115.44% from $5.8 million recorded in FY2023.
  • Praxis Precision Medicines' 5-year Accounts Payables high stood at $14.7 million for FY2022, and its period low was $5.8 million during FY2023.
  • For the 3-year period, Praxis Precision Medicines' Accounts Payables averaged around $11.0 million, with its median value being $12.5 million (2024).
  • In the last 5 years, Praxis Precision Medicines' Accounts Payables tumbled by 60.37% in 2023 and then soared by 115.44% in 2024.
  • Over the past 3 years, Praxis Precision Medicines' Accounts Payables (Yearly) stood at $14.7 million in 2022, then plummeted by 60.37% to $5.8 million in 2023, then skyrocketed by 115.44% to $12.5 million in 2024.